Additionally, the GSEA revealed significant associations between CD109 and YAP signatures in lung cancer patients (Figure 6B), and positive correlations of CD109 and stem-like signatures (Figure 6B), confirming the in vitro findings that CD109 regulates YAP signaling. The gene discussed is YAP1; the disease is lung carcinoma.